美国2018-2023年15岁及以上人群系统性红斑狼疮死亡分析
美国CDC分析2018-2023年15岁及以上死者死亡证明数据,共14,936例提及SLE,其中42.9%以SLE为根本死因。女性、非西班牙裔非裔美国人、西班牙裔及南部地区年龄调整死亡率更高。2020和2021年SLE年龄调整死亡率显著高于其他研究年份,提示COVID-19大流行可能影响SLE死亡率。
要点
- 2018-2023年共14,936例死亡证明提及SLE,42.9%以SLE为根本死因。
- 女性年龄调整SLE死亡率(5.97/百万)高于男性(1.16/百万)。
- 非西班牙裔非裔美国人年龄调整SLE死亡率(10.70/百万)高于其他非西班牙裔种族组(范围2.46-5.62)。
核心结论
- SLE死亡负担存在性别、种族和地区差异,2020和2021年SLE年龄调整死亡率显著升高,提示COVID-19大流行可能影响SLE死亡率。
研究设计与样本
- 美国CDC分析2018-2023年15岁及以上死者死亡证明数据,使用WONDER系统,计算年龄调整死亡率并按性别、年龄、种族和地区评估模式。
主要发现
- 2018-2023年共14,936例死亡证明提及SLE,其中6,414例(42.9%)以SLE为根本死因。
- 女性年龄调整SLE死亡率(5.97/百万)高于男性(1.16/百万)。
- 非西班牙裔非裔美国人年龄调整SLE死亡率(10.70/百万)高于其他非西班牙裔种族组(范围2.46-5.62)。
- 西班牙裔年龄调整SLE死亡率(3.98/百万)高于非西班牙裔(3.59/百万),南部(4.37/百万)高于其他地区。
- SLE为贡献死因时,主要根本死因为心脏病(0.93)、癌症(0.56)和COVID-19(0.51)。
临床怎么用
- 临床应重视SLE患者合并症和感染的综合管理,尤其关注心脏病、癌症和COVID-19。
- 针对非裔美国人等受SLE影响 disproportionate 的人群,可考虑针对性干预以降低SLE死亡率。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Systemic lupus erythematosus (SLE) is a chronic autoimmune condition that can lead to death. To examine SLE as an underlying and contributing cause of death, the Centers for Disease Control and Prevention (CDC) analyzed 2018 to 2023 mortality data for persons aged ≥15 years overall and by age, sex, race and ethnicity, and region. METHODS: Death certificate data for persons aged ≥15 years with any mention of SLE (International Classification of Diseases, Tenth Revision [ICD-10] code M32) were analyzed using the CDC Wide-ranging Online Data for Epidemiologic Research (WONDER) system. We calculated age-adjusted death rates and assessed patterns by sex, age, race and ethnicity, and region. Underlying and contributing causes of death were evaluated using ranked cause-of-death lists and ICD-10 subchapters. RESULTS: During 2018 to 2023, 14,936 deaths had any mention of SLE listed on the death certificates. Of these deaths, 6,414 (42.9%) listed SLE as the underlying cause. The age-adjusted SLE mortality rate per million population was greater among females (5.97) than males (1.16), non-Hispanic African American persons (10.70) than persons of other non-Hispanic racial groups (range 2.46-5.62), Hispanic persons (3.98) than non-Hispanic persons (3.59), and people in the South (4.37) than people in other regions. When SLE was listed as a contributing cause of death, the leading underlying causes were heart disease (0.93), cancer (0.56), and COVID-19 (0.51). The overall age-adjusted SLE mortality rates were significantly higher in 2020 and 2021 than in all other study years, indicating the likely impact of the COVID-19 pandemic on SLE mortality. CONCLUSION: Overall management of SLE, comorbidities, and infections in patients with SLE, as well as interventions targeting groups (eg, African American persons) disproportionately impacted by SLE, may reduce overall SLE mortality.
引用
- Dawson D, Greenlund KJ, Barbour KE, et al. Systemic Lupus Erythematosus Mortality Among Decedents Aged ≥15 Years-United States, 2018-2023. Arthritis Care Res (Hoboken). 2026. PMID: 41524476. doi:10.1002/acr.70042
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。